Week 1 SPSS Assignment 1. Part 1 use your textbook Doing Data Analysis and SPSS 23 to setup and enter data into the data file. This exercise is located on page 1 – 6 of your textbook
Week 1 SPSS Assignment
- Part 1 use your textbook Doing Data Analysis and SPSS 23 to setup and enter data into the data file. This exercise is located on page 1 – 6 of your textbook. You will simply enter the data that is used on page 3 of your text to create your data file. This will provide you with a visual for what this should look like in SPSS. This completes Part 1 (you should save this separately from Part 2).
- Part 2 you will add 5 additional variables to this data set. For example, you might include GPA (and then fill in any GPA #s for each case), you might also use class status (Freshman, Sophomore, Junior and Senior) or any other variables that relates to the set.
- Part 3. Write a short paragraph explaining the second graph with 8 variables. When you have completed this assignment, you should have 2 graphs. One that looks identical to the one on page 3 of your Doing Data textbook and one where you added the 5 additional variables and a paragraph explaining your graph where you added the 5 additional variables.
SPSS V. 24 CD – IBM SPSS Statistics premium GradePack
Order This Solution
49051 Millions developed by 10% and working benefit in 2009 was 15012 Millions that developed by 6%. Roche is contributed CHF. 9874 Millions on R&D in 2009. The free trade stream out 2009 was 8893 that was 79% more than 2008. The aggregate representative of Roche are 81507. Out of them 80115 are changeless. The Sales commitment is more from US that is 38% than West Europe that is 28%. Since pharmaceutical advertising exercises impact the endorsing conduct of specialists, it is of most extreme significance to basically dissect the cases made in the limited time material of the medications. The degree to which pharmaceutical organizations advance the benefits of their items and applicable clinical trails give to specialists are not examined in Pakistan. The consequences of the present logical examination demonstrate that untrustworthy and one-sided claims with respect to the pharmaceutical items are uncontrolled in Pakistan. These medication advancements impact the recommending conduct of the General Practitioners, Consultants in this manner representing one of the possibly significant reasons for outlandish solution. Roche Pakistan Ltd is a Member of IFPMA and PMA and take after their moral business rules to offer its items. Roche Paksitan Ltd is at sixth positioning in Pakistan Pharmaceutical Market and its yearly deal is Rs. 5.2 Billions out of 2009 in Pakistan.>GET ANSWER